Miren Taberna
Institut Català d'Oncologia(ES)St Savas Hospital(GR)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Head and Neck Surgical Oncology, Lung Cancer Treatments and Mutations, Cervical Cancer and HPV Research
Most-Cited Works
- → The Multidisciplinary Team (MDT) Approach and Quality of Care(2020)465 cited
- → Human papillomavirus-related oropharyngeal cancer(2017)395 cited
- → Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma(2018)268 cited
- → Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial(2021)218 cited
- → Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial(2024)181 cited
- → Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651(2022)145 cited
- → Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma(2019)134 cited
- → SEOM clinical guidelines for the treatment of head and neck cancer (2020)(2021)100 cited
- → Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients(2018)80 cited
- → Nutritional changes in patients with locally advanced head and neck cancer during treatment(2017)75 cited